These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 22790205)

  • 1. Ellagitannin from Quercus infectoria eradicates intestinal colonization and prevents renal injuries in mice infected with Escherichia coli O157 : H7.
    Voravuthikunchai SP; Suwalak S; Mitranan W
    J Med Microbiol; 2012 Oct; 61(Pt 10):1366-1372. PubMed ID: 22790205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphological and ultrastructural changes in the cell structure of enterohaemorrhagic Escherichia coli O157:H7 following treatment with Quercus infectoria nut galls.
    Suwalak S; Voravuthikunchai SP
    J Electron Microsc (Tokyo); 2009 Oct; 58(5):315-20. PubMed ID: 19451663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial resistance of Shiga toxin (verotoxin)-producing Escherichia coli O157:H7 and non-O157 strains isolated from humans, cattle, sheep and food in Spain.
    Mora A; Blanco JE; Blanco M; Alonso MP; Dhabi G; Echeita A; González EA; Bernárdez MI; Blanco J
    Res Microbiol; 2005 Aug; 156(7):793-806. PubMed ID: 15921895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decrease in Shiga toxin expression using a minimal inhibitory concentration of rifampicin followed by bactericidal gentamicin treatment enhances survival of Escherichia coli O157:H7-infected BALB/c mice.
    Rahal EA; Kazzi N; Sabra A; Abdelnoor AM; Matar GM
    Ann Clin Microbiol Antimicrob; 2011 Sep; 10():34. PubMed ID: 21906403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probiotic bifidobacteria protect mice from lethal infection with Shiga toxin-producing Escherichia coli O157:H7.
    Asahara T; Shimizu K; Nomoto K; Hamabata T; Ozawa A; Takeda Y
    Infect Immun; 2004 Apr; 72(4):2240-7. PubMed ID: 15039348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence, quantification and isolation of pathogenic shiga toxin Escherichia coli O157:H7 along the production and supply chain of pork around Hubei Province of China.
    Khan SB; Zou G; Xiao R; Cheng Y; Rehman ZU; Ali S; Memon AM; Fahad S; Ahmad I; Zhou R
    Microb Pathog; 2018 Feb; 115():93-99. PubMed ID: 29273508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shiga toxin-producing Escherichia coli (STEC) O22:H8 isolated from cattle reduces E. coli O157:H7 adherence in vitro and in vivo.
    Martorelli L; Albanese A; Vilte D; Cantet R; Bentancor A; Zolezzi G; Chinen I; Ibarra C; Rivas M; Mercado EC; Cataldi A
    Vet Microbiol; 2017 Sep; 208():8-17. PubMed ID: 28888654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibacterial activities of semipurified fractions of Quercus infectoria against enterohemorrhagic Escherichia coli O157:H7 and its verocytotoxin production.
    Voravuthikunchai SP; Suwalak S
    J Food Prot; 2008 Jun; 71(6):1223-7. PubMed ID: 18592749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of immunoglobulin enriched bovine colostrum against oral challenge with enterohaemorrhagic Escherichia coli O157:H7 in mice.
    Funatogawa K; Ide T; Kirikae F; Saruta K; Nakano M; Kirikae T
    Microbiol Immunol; 2002; 46(11):761-6. PubMed ID: 12516772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of colostrum deprivation and concurrent Cryptosporidium parvum infection on the colonization and persistence of Escherichia coli O157 : H7 in young lambs.
    Ragione RM; Best A; Clifford D; Weyer U; Johnson L; Marshall RN; Marshall J; Cooley WA; Farrelly S; Pearson GR; Woodward MJ
    J Med Microbiol; 2006 Jul; 55(Pt 7):819-828. PubMed ID: 16772407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibacterial and immunomodulatory activities of bovine lactoferrin against Escherichia coli O157:H7 infections in cattle.
    Kieckens E; Rybarczyk J; Cox E; Vanrompay D
    Biometals; 2018 Jun; 31(3):321-330. PubMed ID: 29442205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effective medicinal plants against enterohaemorrhagic Escherichia coli O157:H7.
    Voravuthikunchai S; Lortheeranuwat A; Jeeju W; Sririrak T; Phongpaichit S; Supawita T
    J Ethnopharmacol; 2004 Sep; 94(1):49-54. PubMed ID: 15261962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of Escherichia coli O157:H7 excretion in sheep by oral lactoferrin administration.
    Yekta MA; Cox E; Goddeeris BM; Vanrompay D
    Vet Microbiol; 2011 Jun; 150(3-4):373-8. PubMed ID: 21511407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eimeria pragensis infection alters the gut microenvironment to favor extrinsic shiga toxin-producing Escherichia coli O157:H7 colonization in mice.
    Uemura R; Kawakado M; Sueyoshi M; Nonaka N; Horii Y
    Parasitol Int; 2022 Apr; 87():102521. PubMed ID: 34856387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of antibiotic therapy for infection with Shiga-like toxin-producing Escherichia coli O157:H7 in mice with protein-calorie malnutrition.
    Kurioka T; Yunou Y; Harada H; Kita E
    Eur J Clin Microbiol Infect Dis; 1999 Aug; 18(8):561-71. PubMed ID: 10517193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of rifampicin in limiting Escherichia coli O157:H7 Shiga-like toxin expression and enhancement of survival of infected BALB/c mice.
    Rahal EA; Kazzi N; Kanbar A; Abdelnoor AM; Matar GM
    Int J Antimicrob Agents; 2011 Feb; 37(2):135-9. PubMed ID: 21129928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial resistance patterns of Shiga toxin-producing Escherichia coli O157:H7 and O157:H7- from different origins.
    Srinivasan V; Nguyen LT; Headrick SI; Murinda SE; Oliver SP
    Microb Drug Resist; 2007; 13(1):44-51. PubMed ID: 17536933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effects of lactoferrin chimera and bovine lactoferrin in a mouse model of enterohaemorrhagic Escherichia coli O157:H7 infection.
    Flores-Villaseñor H; Canizalez-Román A; Velazquez-Roman J; Nazmi K; Bolscher JG; Leon-Sicairos N
    Biochem Cell Biol; 2012 Jun; 90(3):405-11. PubMed ID: 22332993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shiga toxin-mediated disease in MyD88-deficient mice infected with Escherichia coli O157:H7.
    Calderon Toledo C; Rogers TJ; Svensson M; Tati R; Fischer H; Svanborg C; Karpman D
    Am J Pathol; 2008 Nov; 173(5):1428-39. PubMed ID: 18832584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment with rokitamycin suppresses the lethality in a murine model of Escherichia coli O157:H7 infection.
    Hiramatsu K; Murakami J; Kishi K; Hirata N; Yamasaki T; Kadota J; Shibata T; Nasu M
    Int J Antimicrob Agents; 2003 May; 21(5):471-7. PubMed ID: 12727082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.